Company T&R Biofab Co., Ltd.

Equities

A246710

KR7246710008

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Medical Devices & Implants

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-15 EDT			5-day change	1st Jan Change
7,490 ^KRW	-4.22%		-9.21%	-16.13%

2023	T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
2023	T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI

T&R Biofab Co., Ltd. is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production and sale of three Dimensions (3D) biodegradable polymer printing system, bioinks, 3D organoid and 3D cell therapies, among others. The bioinks are sold under the name of deCelluid. The Company distributes its products within the domestic market and to overseas markets.

KRW in Million	2022	Weight	2023	Weight	Delta
Manufactured Product 74.3 %	-	-	3,864	74.3 %	-
3D Printer Systems, Biodegradable Artificial Supports, and Non-contact Thermometers. 24.9 %	-	-	1,294	24.9 %	-
Service 0.8 %	4	0.1 %	41	0.8 %	+1,073.03%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 88.8 %	4,757	82.7 %	4,615	88.8 %	-2.98%
Vietnam 8.9 %	432	7.5 %	462	8.9 %	+7.06%
Philippines 1.6 %	58	1.0 %	83	1.6 %	+41.29%
Taiwan 0.4 %	39	0.7 %	20	0.4 %	-47.98%
Japan 0.3 %	79	1.4 %	18	0.3 %	-77.07%
Europe 0.0 %	362	6.3 %	1	0.0 %	-99.68%
United States 0.0 %	28	0.5 %	0	0.0 %	-99.47%

Managers	Title	Age	Since
Won-Soo Yoon FOU	Founder	54	-
Young-Pil Kim DFI	Director of Finance/CFO	50	-
Jin-Hyung Shin CTO	Chief Tech/Sci/R&D Officer	39	-
Ju-Sung Sim COO	Chief Operating Officer	54	-
Joo-Hyung Lee AUD	Comptroller/Controller/Auditor	52	-

Members of the board	Title	Age	Since
Won-Soo Yoon FOU	Founder	54	-
Jin-Hyung Shin CTO	Chief Tech/Sci/R&D Officer	39	-
Song-Wan Jin BRD	Director/Board Member	49	-
Heon-Young Kwon BRD	Director/Board Member	56	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	21,546,828	14,601,657 ( 67.77 %)	0	67.77 %

Name	Equities	%	Valuation
Won-Soo Yoon 19.12 %	4,120,656	19.12 %	24 M ₩
KB Asset Management Co. Ltd. 12.03 %	2,592,401	12.03 %	15 M ₩
Jin-Hyung Shin 6.360 %	1,370,320	6.360 %	8 M ₩
Dong-woo Cho 2.799 %	603,000	2.799 %	4 M ₩
Korea Investment Partners Co., Ltd. 2.491 %	536,790	2.491 %	3 M ₩
Woo-Ki Kim 1.154 %	248,565	1.154 %	1 M ₩
National Pension Service of Korea 1.101 %	237,228	1.101 %	1 M ₩
Song-Wan Jin 0.9096 %	195,984	0.9096 %	1 M ₩
ITIX Ltd. 0.9050 %	195,000	0.9050 %	1 M ₩
Ju-Sung Sim 0.2412 %	51,968	0.2412 %	305 318 ₩

T&R Biofab Co., Ltd

No.504, Korea Polytechnic University Techno Innovation Park

15073, Siheung

http://www.tnrbiofab.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Medical Devices & Implants

	1st Jan change	Capi.
T&R BIOFAB CO., LTD.	-16.13%	120M
STRYKER CORPORATION	+11.28%	127B
SMITH & NEPHEW PLC	-4.91%	11.32B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+3.22%	9.04B
GLAUKOS CORPORATION	+38.32%	5.56B
INSPIRE MEDICAL SYSTEMS, INC.	-23.02%	4.72B
AXONICS, INC.	+8.52%	3.45B
ENOVIS CORPORATION	-7.27%	2.86B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-6.99%	2.07B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-13.32%	2.04B

Medical Devices & Implants